CD4 and cancer: The results suggested that the expression of ARPC5 was positively associated with the infiltration level of B cell, CD4+ T cell, CD8+ T cell, neutrophil cell, macrophage cell, and DC cell in most cancer types, especially for KIRC, LGG, PRAD, THCA, and THYM.